Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 39061-97-7 | MDL No. : | MFCD07369246 |
Formula : | C9H5ClN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZRFUZDDJSQVQBY-UHFFFAOYSA-N |
M.W : | 208.60 | Pubchem ID : | 11275808 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 55.58 |
TPSA : | 58.71 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.69 cm/s |
Log Po/w (iLOGP) : | 1.5 |
Log Po/w (XLOGP3) : | 2.65 |
Log Po/w (WLOGP) : | 2.8 |
Log Po/w (MLOGP) : | 1.23 |
Log Po/w (SILICOS-IT) : | 0.86 |
Consensus Log Po/w : | 1.81 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.27 |
Solubility : | 0.113 mg/ml ; 0.000543 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.53 |
Solubility : | 0.061 mg/ml ; 0.000292 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.7 |
Solubility : | 0.0412 mg/ml ; 0.000198 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.88 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With thionyl chloride In dichloromethane; N,N-dimethyl-formamideReflux; Cooling with ice | The Intermediate 3-nitro-4-hydroxyquinoline 70 (18.7 g, 98.4 mmol) was suspended in dichloromethane (150 mL). Thionyl chloride (17.2 mL, 236 mmol) and N,N-dimethylformamide (9.2 mL, 118 mmol) were added. The reaction mixture was then heated at reflux overnight. The reaction mixture was then poured in ice. The layers were separated and the organic layer was washed with NaHCO3 solution, water and brine. The organic layer was dried over Na2SO4, filtered and concentrated in vacuo. The residue (20.52 g, yield 93percent) was used for the next step without any further purification. Methyl 4-((3-nitroquinolin-4-ylamino)methyl)benzoate: |
93% | With thionyl chloride In dichloromethane; N,N-dimethyl-formamide | 4-chloro-3-nitroquinoline The Intermediate 3-nitro-4-hydroxyquinoline 15 (18.7 g, 98.4 mmol) was suspended in dichloromethane (150 mL). Thionyl chloride (17.2 mL, 236 mmol) and DMF (9.2 mL, 118 mmol) were added. The reaction mixture was then heated at reflux overnight. The reaction mixture was then poured in ice. The layers were separated and the organic layer was washed with NaHCO3 solution, water and brine. The organic layer was dried over Na2SO4, filtered and concentrated in vacuo. The residue (20.52 g, yield 93percent) was used for the next step without any further purification. |
81% | for 0.5 h; Heating / reflux | 3-Nitro-4-chIoroquinoIine (compound 6); Compound 6 was prepared as described elsewhere [Van Galen, P. J. M. et. al. 1- H-imidazo[4,5-c]quinolin-4-amines: Novel Non-Xanthine Adenosine Antagonists. J. Med. Chem. 1991, 34, 1202-1206]. In brief, 3-Nitro-4-hydroxyquinoline 5 (5.7 g, 30 mmol) was added to phosphorus oxychlσride (70.0 g, 41.2 ml, 450 mmol) with stirring. <n="22"/>The mixture was refluxed for 30 minutes. After cooling the solvent was poured over crushed ice while stirring. After 1 hour the solid that was formed was filtered off, washed with cold water and dissolved in ethyl acetate. The solution was extracted with ice-cold NaOH (1 M) till ρH= 8-9 and dried over MgSO4. The solvent was evaporated and the residue was dried. Yield: 5.05 g (81percent). Mp.: 118M19 αC. 1H NMR (DMSO- d6): δ 7.94-8.11 (m, 2H, Ar); 8.25 (d, IH5 J= 8.0 Hz5 Ar); 8.47 (d, IH, J= 9.5 Hz, Ar); 9.42 (s, IH, Ar). |
2.3 g | With trichlorophosphate In N,N-dimethyl-formamide at 100℃; for 0.25 h; | Phosphorus oxychloride (2.5 mL, 27 mmol) was added dropwise to a mixture of 3-nitroquinolin-4-ol (4.6 g, 24 mmol) and 100 mL of DMF. The mixture was heated at 100 °C for 15 min, and then poured onto stirred ice. The slurry was neutralized with solid NaHC03, and the precipitate was filtered and washed with saturated NaHC03 and H20. The filtrate was taken up in DCM, dried over anhydrous Na2S04, and concentrated to give 2.3 g of solid. |
[ 723281-72-9 ]
6-Bromo-4-chloro-3-nitroquinoline
Similarity: 0.89
[ 39487-89-3 ]
4-Chloro-3-nitro-8-(trifluoromethyl)quinoline
Similarity: 0.86
[ 723281-72-9 ]
6-Bromo-4-chloro-3-nitroquinoline
Similarity: 0.89
[ 39487-89-3 ]
4-Chloro-3-nitro-8-(trifluoromethyl)quinoline
Similarity: 0.86
[ 723281-72-9 ]
6-Bromo-4-chloro-3-nitroquinoline
Similarity: 0.89
[ 39487-89-3 ]
4-Chloro-3-nitro-8-(trifluoromethyl)quinoline
Similarity: 0.86